Diego Ruiz Espi

Diego Ruiz Espi

Auto-generated profile, based on publicly available information

Diego Ruiz Espi

Center for Translational Protein Design, Technical University of Denmark, Søltofts Plads, Building 221, Kongens Lyngby, 2800, Denmark

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2024 in Toxicon
Verified
Journal Article
Open access
KKKonstantinos Kalogeropoulos
Konstantinos Kalogeropoulos
VRVlad Rosca
Vlad Rosca
COCarol O'BRien
Carol O'BRien
CCCharlotte Risager Christensen
Charlotte Risager Christensen
RGRahmat Grahadi
Rahmat Grahadi
Timothy P. JenkinsTimothy P. Jenkins
Timothy P. Jenkins
Recently, there has been a major push toward the development of next-generation treatments against snakebite envenoming. However, unlike current antivenoms that rely on animal-derived polyclonal antibodies, most of these novel approaches are reliant on an in-depth understanding of the over 2000 known snake venom toxins. Indeed, by identifying similarities (i.e., conserved epitopes) across these different toxins, it is possible to design cross-reactive treatments, such as broadly-neutralising antibodies, that target these similarities. Therefore, in this project, we built an automated pipeline that generates sequence and structural distance matrices and homology trees across all available snake venom toxin sequences and structures. To facilitate analysis, we also developed a user-friendly and high-throughput visualisation tool, coined "Venom TOxin CluStering" (V-ToCs). This tool allows researchers to easily investigate sequence and structure patterns in snake venom toxins for a wide array of purposes, such as elucidating toxin evolution, and will also hopefully help guide the discovery and development of increasingly broadly-neutralising antivenoms in the near future.

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
MOMax D. Overath
Max D. Overath
ELEmil V. S. Lundquist
Emil V. S. Lundquist
KBKasper Haldrup Björnsson
Kasper Haldrup Björnsson
SKSamuel Kerwin
Samuel Kerwin
CJChristian P. Jacobsen
Christian P. Jacobsen
Timothy P. JenkinsTimothy P. Jenkins
Timothy P. Jenkins
Generative protein design can now rapidly produce de novo binders with high affinity and functional activity against a wide range of targets, including lethal snake venom toxins. However, so far most reported successes rely on new-to-nature scaffolds with limited therapeutic precedent. Single-domain antibodies (V H Hs) offer a clinically validated alternative scaffold that can bind and neutralize long-chain α -neurotoxins, which are some of the most lethal components in snake venoms. Here we compare three recently established de novo design models with V H H-design capabilities (Germinal, RFantibody, and BoltzGen) for their ability to generate V H Hs against the neurotoxin α -cobratoxin from the monocled cobra ( Naja kaouthia ). Using standardized model inputs and evaluation criteria based on AlphaFold3 interface confidence (ipTM) and RMSD self-consistency, we find that Germinal was the only method to generate designs passing stringent in silico criteria for experimental testing. We therefore performed a larger Germinal design campaign employing three different V H H frameworks and experimentally validated 46 designs in vitro . Of these, 42 expressed as soluble proteins and we identified four binding hits derived from two of the three tested frameworks. Of the four binders, two lead candidates were further characterized and demonstrated high affinity (K D s of 4.1 nM and 10.8 nM), monomeric behavior and low polyreactivity, indicating favorable biophysical and developability properties, as well as functional toxin neutralization in vitro . To assess their therapeutic potential we investigated their ability to protect against α -cobratoxin toxicity in vivo . Both candidates fully protected mice after α -cobratoxin challenge, with 100% survival compared to a lethal control. One candidate also retained notable neutralization capacity against whole venom of Naja kaouthia with a survival of 56%, while the other protected 22% when tested in a rescue setting. Together, we demonstrate that de novo V H H design can generate high affinity single-domain antibodies with in vivo protection against lethal cobra venom neurotoxicity, and provide practical insights into method- and framework-dependent performance.

20 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DEDiego Ruiz Espi
Diego Ruiz Espi
GMGustavo Avelar Molina
Gustavo Avelar Molina
OBOliver Sonne Buch
Oliver Sonne Buch
JHJulia Heyd
Julia Heyd
AUAske Unger
Aske Unger
Esperanza Rivera-de-TorreEsperanza Rivera-de-Torre
Esperanza Rivera-de-Torre
De novo protein binders can now be generated far faster than they can be tested. Current validation routes — display selection, cell-free two-hybrid assays, or surface-based biophysics — require cell culture, colony picking, protein purification, target labeling or sensor immobilisation, take 2 to 8 weeks, and require additional methods for affinity and kinetics characterisation. Here we report an end-to-end, cell- and purification-free pipeline that goes from gene to binding affinity and kinetics in three days without genetically modified organisms, cell culture, purification, labelling or immobilisation. An automated, metric-driven loop of RFdiffusion, ProteinMPNN and AlphaFold2 initial-guess generates and filters designs, which are ranked by Boltz-2 ipSAE, assembled by Golden Gate cloning from linear DNA, expressed in a cell-free protein synthesis lysate as fluorescent protein fusions, and screened directly in the unpurified product by flow-induced dispersion analysis (FIDA). Against human growth hormone, 11 of 30 designs (37%) bound, and the four strongest had equilibrium dissociation constants of 0.93–9.98 nM with on- and off-rates resolved from the same cell-free material. Each sample run measures expression level, hydrodynamic radius, oligomeric and aggregation state alongside the binding readout, producing the standardised, per-design datasets that model training requires.